Trial Profile
To Evaluate Effects of Boceprevir and Telaprevir-based triple therapy on kidney function in chronic hepatitis C patients with end-stage liver disease score
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 09 Dec 2015 New trial record